| Literature DB >> 17851649 |
C S Yajnik1, S S Deshpande, A A Jackson, H Refsum, S Rao, D J Fisher, D S Bhat, S S Naik, K J Coyaji, C V Joglekar, N Joshi, H G Lubree, V U Deshpande, S S Rege, C H D Fall.
Abstract
AIMS/HYPOTHESIS: Raised maternal plasma total homocysteine (tHcy) concentrations predict small size at birth, which is a risk factor for type 2 diabetes mellitus. We studied the association between maternal vitamin B12, folate and tHcy status during pregnancy, and offspring adiposity and insulin resistance at 6 years.Entities:
Mesh:
Substances:
Year: 2007 PMID: 17851649 PMCID: PMC2100429 DOI: 10.1007/s00125-007-0793-y
Source DB: PubMed Journal: Diabetologia ISSN: 0012-186X Impact factor: 10.122
Fig. 1The PMNS: a flow diagram to describe data collection and exclusions from the study. LMP Last menstrual period
Maternal nutrition data during pregnancy (median and 25th and 75th centiles, unless otherwise stated)
| Number | 18 weeks of gestation | Number | 28 weeks of gestation | |
|---|---|---|---|---|
| Macronutrient intakes | ||||
| Energy (kJ) | 692 | 7,293 (5,858, 8,774) | 670 | 6,803 (5,523, 8,268) |
| Energy (kcal) | 692 | 1,743 (1,400, 2,090) | 670 | 1,626 (1,320, 1,976) |
| Carbohydrate (g) | 692 | 313 (257, 376) | 670 | 296 (236, 360) |
| Protein (g) | 692 | 44.9 (35.4, 54.8) | 670 | 41.7 (33.8, 51.3) |
| Fat (g) | 692 | 32.7 (23.9, 42.9) | 670 | 29.6 (22.4, 39.2) |
| FFQ, | ||||
| GLVs | ||||
| Never | 692 | 15 (2) | 671 | 69 (10) |
| <1 per week | 692 | 139 (20) | 671 | 197 (29) |
| >1 per week | 692 | 277 (40) | 671 | 243 (36) |
| >Alternate day | 692 | 261 (38) | 671 | 162 (24) |
| Dairy products, | ||||
| Never | 692 | 107 (15) | 671 | 96 (14) |
| <1 per week | 692 | 141 (20) | 671 | 137 (20) |
| >1 per week | 692 | 129 (19) | 671 | 144 (21) |
| >Alternate day | 692 | 315 (46) | 671 | 294 (44) |
| Non-vegetarian foods, | ||||
| Never | 692 | 228 (33) | 671 | 254 (38) |
| <1 per week | 692 | 182 (26) | 671 | 181 (27) |
| >1 per week | 692 | 182 (26) | 671 | 149 (22) |
| >Alternate day | 692 | 100 (14) | 671 | 87 (13) |
| Circulating micronutrients | ||||
| Vitamin B12 (pmol/l) | 638 | 135 (103, 175) | 594 | 122 (94, 160) |
| <150 pmol/l, | 380 (60) | 423 (71) | ||
| Erythrocyte folate (nmol/l) | 618 | 874 (687, 1,106) | 562 | 961 (736, 1,269) |
| <283 nmol/l, | 1 (0.2) | 1 (0.2) | ||
| MMA (μmol/l) | 636 | 0.80 (0.50, 1.34) | 594 | 0.73 (0.44, 1.18) |
| >0.26 μmol/l, | 586 (94) | 533 (90) | ||
| tHcy (μmol/l) | 639 | 8.1 (6.8, 10.3) | 593 | 8.6 (6.7, 10.8) |
| >10 μmol/l, | 177 (28) | 193 (33) | ||
Dairy products refers to whole milk plus milk products (milk in tea and other beverages, yoghurt, buttermilk, ghee, ice cream and other milk-based preparations). Non-vegetarian foods are meat, fish and eggs
Characteristics of the children at 6 years (n = 653)
| Median (IQR) | Mean SD scorea (SD) | |
|---|---|---|
| Age (years) | 6.1 (6.1, 6.2) | |
| Weight (kg) | 16.0 (14.8, 17.3) | −2.23 (1.00) |
| Height (cm) | 109.7 (106.7, 112.9) | −1.39 (0.89) |
| BMI (kg/m2) | 13.3 (12.8, 14.0) | −1.86 (0.90) |
| Subscapular skinfold thickness (mm) | 5.0 (4.4, 5.6) | −0.42 (0.68) |
| Triceps skinfold thickness (mm) | 6.2 (5.4, 7.1) | −1.41 (0.79) |
| Fat mass (kg) | 3.1 (2.4, 3.7) | |
| Fat (%) | 18.8 (15.5, 22.2) | |
| Leg fat mass (kg) | 1.3 (1.0, 1.5) | |
| Trunk fat mass (kg) | 0.9 (0.7, 1.2) | |
| Lean mass (kg) | 12.7 (11.7, 13.7) | |
| Insulin resistance (HOMA-R) | 0.70 (0.37, 1.06) | |
| 120 min glucose (mmol/l) | 5.49 (4.82, 6.21) | |
| Vitamin B12 (pmol/l) | 224 (167, 311) |
aSD scores at 6 years were derived from the UK growth standards [26, 28]
IQR Interquartile range
Outcomes in the children at 6 years (body composition and insulin resistance) according to maternal vitamin B12 concentrations at 18 weeks, erythrocyte folate at 28 weeks and GLV and dairy product intake at 28 weeks
| Number | Height (cm) | Fat mass (kg) | Lean mass (kg) | Insulin resistance (HOMA-R) | ||
|---|---|---|---|---|---|---|
| Vitamin B12 at 18 weeks (pmol/l) | ||||||
| <103 | 146 | 110.2 (4.3) | 3.3 (0.9) | 12.8 (1.6) | 0.78 (0.42, 1.34) | |
| 103–134 | 150 | 109.3 (4.6) | 3.0 (1.0) | 12.7 (1.5) | 0.68 (0.35, 0.99) | |
| 135–174 | 145 | 109.6 (4.9) | 3.1 (1.0) | 12.9 (1.7) | 0.69 (0.30, 0.95) | |
| ≥175 | 151 | 110.0 (4.9) | 3.2 (1.0) | 12.8 (1.7) | 0.61 (0.35, 1.00) | |
| | 0.8 | 0.5 | 0.3 | 0.03 | ||
| | 0.6 | 0.4 | 0.3 | 0.04 | ||
| Erythrocyte folate at 28 weeks (nmol/l) | ||||||
| <734 | 129 | 109.2 (4.6) | 3.0 (1.0) | 12.8 (1.7) | 0.52 (0.28, 0.81) | |
| 734–691 | 136 | 109.8 (4.5) | 3.1 (0.9) | 12.9 (1.6) | 0.65 (0.36, 0.92) | |
| 962–1,268 | 131 | 109.9 (4.7) | 3.2 (1.2) | 12.7 (1.8) | 0.71 (0.39, 1.12) | |
| ≥1,269 | 127 | 110.7 (4.8) | 3.4 (1.1) | 13.0 (1.6) | 0.85 (0.51, 1.27) | |
| | 0.02 | 0.001 | 0.5 | <0.001 | ||
| | 0.7 | 0.01 | 0.4 | <0.001 | ||
| GLVs at 28 weeks | ||||||
| Never | 63 | 109.1 (5.5) | 3.0 (0.9) | 12.5 (1.7) | 0.83 (0.25, 1.23) | |
| <Once per week | 183 | 109.5 (4.7) | 3.0 (1.0) | 12.7 (1.7) | 0.73 (0.36, 1.05) | |
| >Once per week | 231 | 109.8 (4.6) | 3.2 (1.0) | 12.8 (1.7) | 0.69 (0.34, 0.99) | |
| ≥Alternate days | 146 | 110.5 (4.1) | 3.3 (1.2) | 13.0 (1.6) | 0.66 (0.41, 1.00) | |
| | 0.002 | 0.001 | 0.01 | 0.99 | ||
| | 0.4 | 0.02 | 0.4 | 0.98 | ||
| Dairy products at 28 weeks | ||||||
| Never | 87 | 108.4 (4.9) | 2.9 (0.9) | 12.6 (1.8) | 0.60 (0.32, 0.95) | |
| <Once per week | 124 | 110.2 (4.1) | 3.2 (1.0) | 12.8 (1.6) | 0.62 (0.37, 0.99) | |
| >Once per week | 134 | 109.4 (4.6) | 3.2 (0.9) | 12.7 (1.7) | 0.73 (0.40, 1.06) | |
| ≥Alternate days | 278 | 110.3 (4.6) | 3.2 (1.2) | 12.9 (1.7) | 0.74 (0.37, 1.11) | |
| | 0.005 | 0.03 | 0.3 | 0.02 | ||
| | 0.2 | 0.2 | 0.8 | 0.006 | ||
Values are mean (SD) or median (interquartile range)
ap value adjusted for the child’s age and sex
bp value adjusted for the above, plus: SES, the mother’s pre-pregnant height and fat mass, the child’s birthweight, skinfold thicknesses and gestation at delivery and the mother’s protein intake at the time of measurement
Fig. 2Insulin resistance (HOMA-R) in the children at 6 years in relation to maternal vitamin B12 (18 weeks) and erythrocyte folate (28 weeks)
Multiple linear regression models for child’s insulin resistance (HOMA-R) at 6 years as the dependent variable
| Independent variable | Model 1 | Model 2 | Model 3 | Model 4 | ||||
|---|---|---|---|---|---|---|---|---|
| Plasma vitamin B12 at 18 weeks (pmol/l) | −0.16 | 0.03 | −0.16 | 0.04 | ||||
| Erythrocyte folate at 28 weeks (nmol/l) | 0.38 | <0.001 | 0.38 | <0.001 | ||||
| Interaction term (vitamin B12 × folate) | −0.08 | 0.7 | ||||||
The independent variable included maternal plasma vitamin B12 concentration at 18 weeks gestation, erythrocyte folate at 28 weeks gestation, child’s age, sex, fat mass and standard of living index. The models progressively included vitamin B12, erythrocyte folate, both, and an interaction term (models 1 to 4, respectively)
Fig. 3The groups of variables used in the PCAs are described in Statistical methods. The notation F1–F3 indicates the first to third principal components, or factors (F), derived from each group of variables. Lines connecting boxes indicate significant positive correlations (p < 0.01), and bold lines denote correlations significant at p < 0.001. Correlations labelled A–D are explained in the Results (PCA and conditional independence analysis). Veg Vegetables